Related by context. All words. (Click for frequent words.) 81 clinicaltrials.gov 79 www.clinicaltrials.gov 77 http:/www.clinicaltrials.gov 75 number NCT# ClinicalTrials.gov 75 NCT# 74 Clinicaltrials.gov 72 www.ClinicalTrials.gov 67 http:/www.clinicaltrials.gov/ 67 ID NCT# 67 identifier NCT# 64 www.asco.org 63 Current Controlled Trials 63 ClinicalTrials.gov Identifier NCT# 63 dbGaP 62 NCT# ClinicalTrials.gov 62 cancer.gov 62 BRIM3 61 Intervention Trial GAIT 61 drugs.com 61 www.cellceutix.com 61 AIM HIGH 61 Cellceutix web 60 TAXUS ARRIVE 60 Digital Mammographic Imaging 60 Intervention Effectiveness 60 www.aacr.org 60 ISRCTN# 60 ENDEAVOR IV 60 ENESTnd 60 BRIM2 60 ONTARGET 59 Clinical Antipsychotic Trials 59 LUMINATE 59 EMBASE 59 confirmatory Phase IIIb 59 clinicaltrials 59 ACUITY trial 59 EVEREST II 59 Edge STudy 59 Clinical Trials Registry 59 www.thelancet.com 59 ThermoDox ® clinical 59 BR.# 59 Screening Trial DMIST 59 National Oncologic PET 59 Prostate Cancer Prevention 58 Arch Intern Med 58 Arch Surg 58 http:/www.ncbi.nlm.nih.gov/pubmed/# 58 http:/www.hematology.org 58 Registry NOPR 58 EDEMA3 58 CALGB 58 Glucosamine Chondroitin Arthritis 58 ICMJE 58 Trandolapril 58 Full Prescribing Information 58 randomized controlled trials RCTs 58 GATTEX ® 58 www.cancer.gov 58 VADT 58 HPTN 58 prelicensure 58 PERSEUS 58 phase IIb clinical 58 CURRENT OASIS 7 58 INTERMACS 58 www.marrow.org 58 www.annals.org 58 nih.gov 58 ExTRACT TIMI 58 CaPSURE 58 BCIRG 58 NeuroStar TMS Therapy 58 Acute Decompensated Heart Failure 58 multicentre prospective 57 ongoing Phase 1b 57 Carotid Revascularization Endarterectomy vs. 57 NATRECOR R 57 prospective multicentre 57 randomized Phase III 57 Pubmed 57 www.nejm.org 57 multicenter randomized controlled 57 GLOBOCAN 57 Serious Adverse Events 57 AVERROES 57 www.morrishospital.org 57 www.celsion.com 57 Stenting Trial CREST 57 CUSTOM II 57 www.hematology.org 57 RE LY 57 PREVENT IV 57 MADIT 57 APEX AMI trial 57 Environ Health Perspect 57 MADIT II 57 www.genome.gov 57 National Guideline Clearinghouse 57 DAPT Study 57 assessing T DM1 57 phase IIa clinical 57 NCI Cancer 57 nonrandomized 56 Glucosamine chondroitin Arthritis 56 randomized controlled multicenter 56 multicenter multinational 56 ToGA 56 Oral Insulin Capsule 56 Deborah Zarin 56 JACC Cardiovascular Interventions 56 CLARITY TIMI 56 phase IIIb 56 www.centerwatch.com 56 treatment naive genotype 56 Left Ventricular Dysfunction 56 PubMed 56 www.hospitalcompare.hhs.gov 56 ASSERT 56 www.alexionpharma.com 56 ZACTIMA 56 RE LY ® 56 NCCN.org 56 HCV SPRINT 56 Diabetologia 56 IMPROVE HF 56 care.org 56 www.roche 56 prospective nonrandomized 56 www.nature.com 56 ANN INTERN MED 56 MAGE A3 ASCI 56 prospective multicenter 56 BMC Musculoskeletal Disorders 56 Prescribing Information 56 TMC# C# 56 multicentre randomized 56 ANCHOR trial 56 MedLine 56 Proellex TM 56 PROactive study 56 MEDLINE 56 Intervention Effectiveness CATIE 56 ZOLINZA 56 SYMMETRY trial 56 clevidipine 56 brivanib 56 rALLy trial 56 news subscribe.htm 56 WEB OF SCIENCE 55 www.stemcellsinc.com 55 ACCORD Lipid 55 lipid lowering drugs 55 CALGB # [002] 55 Multicenter AIDS 55 BARI 2D 55 STRIDE PD 55 prospectively defined 55 BOLDER II 55 ENDEAVOR III 55 Stenting Trial 55 PGRN 55 Triapine R 55 CHAMPION PCI 55 cro.com 55 assn.org 55 prospective randomized placebo 55 NSABP 55 EURIDIS 55 Prostate AdenoCarcinoma Treatment 55 Phase #b/#a clinical 55 CATIE AD 55 Recurrent Glioblastoma 55 Arch Neurol 55 www.aan.com 55 BrainGate TM 55 See CLINICAL PHARMACOLOGY 55 Aplidin R 55 via Wiley InterScience 55 http:/www.atherogenics.com 55 NCCTG 55 Hepatocellular Carcinoma HCC 55 placebo controlled clinical 55 www.oncolyticsbiotech.com 55 www.bdal.com 55 fosbretabulin 55 www.niddk.nih.gov 55 oral ridaforolimus 55 galiximab 55 EchoCRT 55 Val HeFT 55 TRITON TIMI 55 Hepatotoxicity 55 visit www.lupus.org 55 Phase IIIb 55 ARCOXIA 55 Oral Fingolimod 55 Screening Trial 55 lumiracoxib 55 tarenflurbil 55 Phase Ib II 55 www.syntapharma.com 55 TG MV 55 www.boehringer ingelheim.com 55 Severe Asthma 55 Phase III placebo controlled 55 Am J Epidemiol 55 www.gsk.com 55 NSABP B 55 Patient Registry 55 multicenter Phase III 55 Multicenter Automatic Defibrillator Implantation 55 www.adventrx.com 55 retrospective cohort 54 www.cdc.gov nchs 54 alvespimycin 54 fluvastatin 54 Randomized Controlled Trials 54 Gynecologic Oncology Group 54 Eur Urol 54 APPRAISE 54 USpella 54 designated HVTN 54 ORAL Sync 54 CARE HF 54 ADHERE 54 Matrix Phase 2b 54 #:#-# [032] 54 angiotensin receptor blockers 54 Randomized Controlled 54 www.cancerconsultants.com 54 Renal Cell Carcinoma RCC 54 DynaMed 54 ENGAGE AF TIMI 54 RCTs 54 ADVANCE PD 54 Sprycel dasatinib 54 ECASS 54 med.com 54 riociguat 54 ASCO GI 54 Phase III Pivotal 54 Catheterization 54 PRECiSE 54 LUX Lung 54 Phase III HEAT 54 http:/www.oncolyticsbiotech.com 54 APPROVe 54 www.telik.com 54 HCV RESPOND 2 54 acyclovir Lauriad R 54 atherothrombosis 54 prucalopride 54 CONQUER OB 54 Investigational Drug 54 ELCAP 54 RhuDex 54 heFH 54 Medwatch 54 Dialysis Outcomes 54 NABTT 54 Nesiritide 54 SCD HeFT 54 Pafuramidine 54 clinically meaningful differences 54 crizotinib PF # 54 Cancer Immunology Immunotherapy 54 Contraindications 54 Package Insert 54 Diabetic Medicine 54 PrevOnco 54 www.nih.gov 54 confirmatory clinical 54 Product Monograph 54 ASTEROID 54 Phase III AFFIRM 54 ALLHAT 54 FOLOTYN ® 54 www.consumerlab.com 54 dotMobi domain 54 www.gpc biotech.com 54 Cholesterol Levels SPARCL 54 evaluating tivozanib 54 www.med 54 www.accentia.net 54 Pharmaprojects 54 www.avigen.com 54 www.sanofi aventis.us 54 www.novartis.com 54 SORT OUT III 54 r hGH 54 PFO migraine 54 BENICAR HCT 54 Pentacel vaccine 54 Vimpat R 54 J Am Coll 54 Phase III multicenter 54 www.aidshealth.org 54 resectable pancreatic cancer 54 MERLIN TIMI 54 randomized Phase IIb 54 PLCO 54 Phase III ThermoDox 54 #-# Full Text 54 rALLy clinical trial 54 phase IIb study 54 www.pnas.org 54 CIMZIA TM certolizumab pegol 54 Diamyd r 54 CALERIE 54 Brentuximab Vedotin SGN 54 Randomized Phase II 53 www.nimh.nih.gov 53 journal Lancet Neurology 53 Arch Pediatr Adolesc Med 53 EXPLORE Xa 53 http:/www.vivus.com 53 www.interscience.wiley.com 53 register.php 53 Int Clin Psychopharmacol 53 Ranolazine 53 ticagrelor Brilinta 53 ACS NSQIP 53 hypereosinophilic syndrome 53 TAXUS IV 53 Systemic Lupus Erythematosus SLE 53 Tanespimycin 53 www.pranabio.com 53 HYVET 53 Velcade bortezomib 53 Pivotal Phase III 53 HeFT 53 iPrEx 53 placebo controlled Phase III 53 ezogabine 53 www.flucliniclocator.org 53 substudy 53 brivaracetam 53 www.ingenuity.com 53 Aggressive Reduction 53 CAMMS# 53 www.health 53 Advaxis Phase 53 ASCO abstract 53 HORIZONS AMI 53 Delcath Phase III 53 www.nlm.nih.gov 53 PROTECT AF 53 www.phtcorp.com 53 http:/www.americanregistry.com 53 R rosiglitazone maleate 53 Acute Ischemic Stroke 53 ACCOMPLISH 53 www.vioquestpharm.com 53 biliary tract cancer 53 Zestra R 53 placebo controlled clinical trials 53 Am J Pathol 53 pivotal bioequivalence 53 PUBMED 53 Fingolimod 53 Truvada tablets 53 journal Rheumatology 53 grants.gov 53 J Clin Oncol 53 prospective randomized multicenter 53 CIBMTR 53 YONDELIS 53 www.bioalliancepharma.com 53 coxib 53 iPrEx study 53 ROCKET AF 53 multicenter Phase II 53 General Psychiatry #:#-#,# 53 landmark ATHENA 53 SPIRIT IV 53 Acthar Gel 53 Fondaparinux 53 http:/www.curagen.com 53 Randomized Double blind 53 #:# -# [002] 53 multicenter clinical 53 recurrent glioblastoma multiforme 53 XL# SAR# 53 Chronic Heart Failure 53 Study ADCS 53 www.allos.com 53 SPARCL 53 active comparator 53 http:/jasn.asnjournals.org/ 53 CAPRIE 53 ß blockers 53 double blinded randomized 53 DEXILANT 53 Randomized Evaluation 53 duloxetine Cymbalta 53 reboxetine 53 randomized multicenter 53 AA Amyloidosis 53 Clinical Psychopharmacology 53 AVANDIA 53 http:/www.diabetes.org 53 ACTIVE W 53 http:/www.ariad.com 53 rFVIIa 53 TASKi2 53 multicentre 53 OncologySTAT 53 Phase III randomized controlled 53 Vaccine Immunology 53 PROSTVAC TM 53 NATRECOR ® 53 Psychopharmacol Bull 53 ASCO Annual Meeting 53 Spine Patient Outcomes 53 REVEAL Registry 53 midstage clinical 53 www.vivus.com 53 Severe Sepsis 53 Ann Intern Med 53 visit www.marrow.org 53 Refractory Angina 53 www.grants.gov 53 metastatic neuroendocrine tumors 53 JBJS 53 metastatic GIST 53 AVOREN 53 NEJM.org 53 www.vote smart.org 53 aripiprazole Abilify 53 aldosterone antagonists 53 journal Critical Care 53 Phytotherapy Research 53 www.pgxhealth.com 53 Phase Ib clinical 53 CLARITY study 53 www.nami.org 53 GAMMAGARD 53 Diabetic Neuropathy 53 PROMACTA CARES 53 Prospective Multicenter 53 Prostate Lung Colorectal 53 antiepileptics 53 Daxor 53 Randomized Phase 53 novel VDA molecule 53 Combination REOLYSIN R 53 Randomized controlled 53 Endovascular Valve Edge 53 journal PloS 53 Sipuleucel T 53 multicenter prospective 53 Phase 1a clinical 53 See WARNINGS 53 EmbraceAC 53 Schizophrenia Bulletin 53 MIST II 53 Phase IIIb clinical 53 Medtronic CareLink Network 53 abstracts summarizing 53 PDX pralatrexate 53 journal Hepatology 53 RE LY trial 53 Viagra sildenafil 53 ARBITER 6 53 Medullary Thyroid Cancer 53 http:/www.baxa.com 52 Cardiotoxicity 52 journal Arteriosclerosis Thrombosis 52 Outpatient Setting 52 REACH Registry 52 PANVAC VF 52 MedlinePlus 52 teriflunomide 52 www.cardiome.com 52 cobiprostone 52 CINAHL 52 blinded randomized placebo controlled 52 randomized discontinuation trial 52 BEXXAR Therapeutic Regimen 52 multicenter trials 52 multicenter placebo controlled 52 mg BID dose 52 Systematic Reviews 52 KRN# 52 lorcaserin Phase 52 Hydroxyurea 52 REALITY Trial 52 SWOG 52 www.ecri.org 52 Investigator Initiated 52 randomized controlled clinical 52 DF HCC 52 BOXED WARNING 52 Maven Semantic 52 SCIg 52 Human Mutation 52 subanalysis 52 http:/www.gpc-biotech.com 52 PLoS Clinical Trials 52 recurrent malignant glioma 52 www.vicortech.com 52 Evaluation WISE 52 Ceflatonin 52 INTEGRILIN R 52 www.nhlbi.nih.gov 52 controlled multicenter Phase 52 CIMZIA ™ 52 BRILINTA 52 www.cms.hhs.gov 52 BZA CE 52 R lenalidomide 52 www.SIRweb.org 52 www.marshalledwardsinc.com 52 ACRIN 52 Hedgehog Pathway Inhibitor 52 placebo controlled studies 52 SWiTCH 52 www.aaos.org 52 dose escalation phase 52 muraglitazar 52 topical calcineurin inhibitors 52 paroxetine Paxil 52 MEND CABG 52 Endocrine Practice 52 Lung Screening 52 PubChem 52 www.lonza.com 52 REMINYL ® 52 placebo controlled trials 52 Fabry Disease 52 journal Molecular Psychiatry 52 DAPT 52 Diabetes ACCORD 52 recurrent glioma 52 HORIZONS AMI trial 52 Tesmilifene 52 mertansine 52 randomized multicentre 52 LibiGel ® 52 phase IIb trial 52 sirolimus eluting stents 52 Nasdaq PPHM 52 Antimicrobial Chemotherapy 52 colorectal liver metastases 52 Elitek 52 www.xoma.com 52 relapsed MM 52 Mg Usa 52 www.osteologix.com 52 journal Epilepsia 52 AASLD 52 Warfarin Coumadin 52 www.imls.gov 52 www.acusphere.com 52 mg administered orally 52 JAMA #:#-# 52 Interventional Radiology interventional radiologisiceberg lettuces 52 INTERHEART study 52 cancer.org 52 relapsing multiple sclerosis 52 www.healthgrades.com 52 pharmacokinetic PK 52 programs visit http:/www.bionovo.com 52 florbetaben 52 www.verichipcorp.com 52 multicenter randomized clinical 52 http:/www.grants.gov 52 SPIRIT FIRST 52 journal Resuscitation 52 Prospective Randomized 52 SIMCOR 52 RIO Lipids 52 www.familysearch.org 52 Randomised 52 Phase III VISTA 52 Disease GOLD 52 Erythropoiesis Stimulating Agents ESAs 52 Pediatric Oncology Branch 52 International Verapamil SR 52 www.eclipse.org 52 Systemic Sclerosis 52 CYT# potent vascular disrupting 52 PRE SURGE 52 randomized multicenter trial 52 Cloretazine 52 Arch Dermatol 52 DIRECT Trial 52 Coronary Artery Bypass Graft 52 sertraline Zoloft 52 ModernHealthcare.com 52 tasocitinib 52 Complete Prescribing Information 52 tipranavir 52 ENTEREG 52 Meta analyzes 52 Translational Science Award 52 6R BH4 52 randomized controlled Phase 52 Molecular Cancer 52 www.iihs.org 52 Ovarian PLCO Cancer 52 ixabepilone 52 placebo controlled Phase 52 Ann Rheum Dis 52 SABCS 52 Acta Psychiatrica Scandinavica 52 Ann Oncol 52 FASEB J. 52 hyaluronidase enzyme 52 FULL PRESCRIBING INFORMATION 52 RTOG 52 Antiviral Therapy 52 www.sciencemag.org 52 Cancer Genetic Markers 52 Perforomist Inhalation Solution 52 antiarrhythmic drug 52 SIMPADICO 52 www.whitepages.com 52 #:# -# [004] 52 cell.com 52 Multicenter 52 Pulmonary Arterial Hypertension 52 TELCYTA 52 CJASN 52 heart.org 52 Alzheimer Disease Cooperative 52 www.hhs.gov 52 meta analyzes 52 Therapeutics TCT scientific 52 J Pediatr 52 Phase 2b Study 52 ezetimibe simvastatin 52 trastuzumab DM1 T DM1 52 J Nerv Ment Dis 52 JAAPA 52 Clinical Therapeutics 52 www.healthcare.gov 52 Tumor Response 52 Advanced Renal Cell 52 OvaRex ® MAb 52 www.baxa.com 52 Diabetic Nephropathy 52 prospective longitudinal 52 refractory Hodgkin lymphoma 52 http:/www.nichd.nih.gov/ 52 Acute Stroke 52 AREDS 52 Epidemiological Studies Unit 52 EuroIntervention 52 Cancer Incidence Mortality 52 Br J Cancer 51 Radiation Therapy Oncology 51 ADNI 51 multicenter randomized 51 dabigatran 51 please visit www.advaxis.com 51 dbSNP 51 PARTNER Trial 51 CAPRISA 51 Ralivia TM 51 tibolone 51 www.scott 51 #:#-# [033] 51 NSABP C 51 trials RCTs 51 Valopicitabine 51 vildagliptin 51 en US 51 Relapsing Multiple Sclerosis 51 vismodegib 51 reslizumab 51 NeuroImage 51 registrational Phase 51 www.ziopharm.com 51 www.anthera.com 51 subgroup analyzes 51 #th Annual Interscience 51 CYPHER Stent 51 Quality Indicators 51 Cochrane Database 51 endometriosis ovarian cysts 51 http:/www.americanheart.org 51 Acute Myocardial Infarction 51 PloS ONE 51 prospective observational studies 51 Etanercept 51 MEVACOR 51 http:/www.medicare.gov 51 #:#-# [006] 51 PRIALT 51 mycophenolate mofetil 51 atorvastatin Lipitor 51 ATACAND 51 ISSN #-# 51 www.advaxis.com 51 MEDLINE database 51 Haemostasis 51 http:/www.sciencedirect.com 51 certolizumab 51 www.paintrials.com 51 AIR CF2 51 J Clin Endocrinol Metab 51 www.sembiosys.com 51 MTWA testing 51 journal Gynecologic Oncology 51 EMBO Molecular Medicine 51 non nucleoside inhibitor 51 E Tryton 51 observational cohort 51 VFEND 51 sunitinib malate 51 VICTOR E1 51 HMG CoA reductase inhibitors 51 www.cerus.com 51 ASH Annual Meeting 51 Dabigatran 51 entitled Synergistic 51 www.regenerx.com 51 Pivotal Trial 51 Cochrane Database Syst Rev 51 ORENCIA R 51 www.isecuretrac.com 51 LymphoStat B 51 J Allergy Clin 51 PRESEPT 51 PI3K/Akt pathway inhibitor 51 www.resverlogix.com 51 Free Full Text 51 www.agennix.com 51 www.hceda.org 51 Gynecological Cancer 51 Cohort Study MACS 51 www.ada.org 51 GSK# [001] 51 UST Libraries 51 Nexavar prescribing 51 Abilify aripiprazole 51 Initiate Phase II 51 NeedyMeds 51 Phase 2b Clinical Trial 51 www.pbmi.com 51 www.nymox.com email info@nymox.com 51 Ambulatory EHR ensures 51 observational cohort study 51 #:#-# [029] 51 metastatic CRC 51 elacytarabine 51 rosuvastatin Crestor 51 Biotechnology Information NCBI 51 multicenter 51 pharmacogenomic translational research 51 www.chi.org 51 Evaluating Patient Outcomes 51 www.webmd.com 51 papillary renal cell carcinoma 51 http:/www.adventrx.com 51 pertuzumab 51 uk domain 51 http:/www.nasd.com 51 fidaxomicin Phase 51 BioMarck 51 Dr. Kandzari 51 www.ncoa.org 51 candesartan cilexetil 51 www.iconplc.com 51 www.systemc.org 51 Zenvia Phase III 51 PLoS ONE journal 51 lipid lowering agents 51 Clinical Outcomes Utilizing Revascularization 51 Clostridium difficile Infection 51 journal Ophthalmology 51 oral rivaroxaban 51 glatiramer 51 tenofovir emtricitabine 51 IMPACT DCM 51 medicare.gov 51 Cethromycin 51 Pre RELAX AHF 51 LCP Tacro ™ 51 tumor histology 51 DEB# 51 www.infinitiusa.com 51 journal Oncogene 51 Neuroepidemiology 51 Obes Res 51 MKC# MKC# PP 51 article #.#/NEJMoa# 51 Torisel 51 PCV# 51 National Emphysema Treatment 51 CLINICAL PHARMACOLOGY 51 Visit GITA 51 ALTROPANE 51 Kidney Disorders 51 entecavir 51 HIV HCV coinfected 51 Flu.gov 51 GENERIC SILDENAFIL SOFT Generic 51 retrospective observational study 51 Sunesis Pharma 51 OPT CHF 51 America HFSA 51 Common Toxicity Criteria 51 CERVARIX R 51 www.fda.gov 51 www.michaeljfox.org 51 Specifid 51 Cotavance 51 Aggressive Drug Evaluation 51 Malignant Mesothelioma 51 www.heritage.org 51 http:/www.telnic.org 51 Peer Reviewed Medical 51 undergone radical prostatectomy 51 www.micromet.com 51 please visit www.anci 51 prospective observational cohort 51 Initiate Phase 51 receiving SIMPONI 51 NCCN Drugs 51 prasugrel Effient 51 opioid naive 51 RevAssist R 51 EBMT criteria 51 http:/www.npsp.com 51 paliperidone ER 51 Zarnestra 51 rALLy 51 chromium supplementation 51 CR# vcMMAE 51 J Am Acad 51 journal Genome Biology 51 neratinib 51 J Natl Cancer Inst 51 oral FTY# 51 PTNS 51 System USRDS 51 www.uspto.gov 51 Therapeutic Advances 51 visit www.sanofi aventis.us 51 AIR2 Trial 51 iclaprim 51 Rilonacept 51 sorafenib tablets 51 Celecoxib APC trial 51 eribulin mesylate 51 Wisconsin Sleep Cohort 51 PREZISTA r 51 Clinical Practice Guideline 51 journal Menopause 51 www.givenimaging.com 51 Medical Subject Headings 51 k Premarket Notification 51 Multicentre 51 www.stevens.edu 51 Nat Genet 51 Phase III Clinical Trial 51 doi #.# 50 ScienceExpress 50 Quinamed 50 PET FROM 50 sipuleucel T 50 journal Anesthesiology 50 www.clevelandclinic.org 50 Randomized Double Blind 50 Cancer Institute www.cancer.gov 50 TrialWorks 50 sorafenib Nexavar 50 AVADO 50 www.achillion.com 50 IL# PE#QQR 50 Google Safe Browsing 50 StockPreacher please 50 Dr. Pasinetti 50 Medindia 50 randomized controlled clinical trials 50 Cloretazine ® 50 evaluating Actimmune 50 www.aaaai.org 50 journal Transfusion 50 FDA CDER 50 Randomized Study 50 MGd 50 Lancet Oncology journal 50 ASBMR 50 protease inhibitor PI 50 compendia 50 ABLAVAR ™ 50 Afinitor everolimus 50 Clinical Neuropsychology 50 www.oxigene.com 50 periprocedural MI 50 AFRS TM 50 Clinical Oncology JCO 50 carotid endarterectomy CEA 50 Arthritis Rheum 50 aldosterone antagonist 50 J Immunol 50 CoreValve System 50 Cardiovascular Interventions 50 atherothrombotic disease 50 Novel Antibiotic 50 http:/www.gene.com/ 50 label multicenter randomized 50 blinded randomized 50 clobazam 50 Zemplar Capsules 50 intravesical infusion therapy 50 prospective observational 50 clinical trial 50 metastatic HRPC 50 non nucleoside HCV 50 AVONEX PEN 50 www.epeat.net 50 PubMed database 50 QuadraSphere 50 Ann Emerg Med 50 Acta Scandinavica 50 myelodysplastic myeloproliferative diseases 50 HF ACTION 50 Myocardial Infarction 50 Initiates Phase 2b 50 http:/www.vical.com 50 ASCO GU 50 Obstet Gynecol 50 randomized clinical 50 TNFerade TM 50 naproxen esomeprazole magnesium 50 programs visit http:/www.nih.gov/ 50 ARIXTRA R 50 dose escalation clinical 50 Pharmacokinetic Study 50 PRECISE 50 Intervention Trial 50 clinico pathological 50 Initiates Phase III 50 PRIMO CABG2 50 OPTIMIZE HF 50 Drugs.com 50 www.mayoclinic.org 50 invasive aspergillosis 50 MEDMARX 50 SYNTAX Score 50 SANTE 50 rt PA 50 recurrent GBM 50 GISAID 50 MoxDuo IR 50 HIVNET 50 www.durect.com 50 www.cablelabs.com 50 doi #.#/S#-# 50 Syllego system 50 visit www.aan.com 50 Unstable Angina 50 nonrandomized studies 50 www.calypto.com 50 PCI ExTRACT TIMI 50 Clinical Trial Data 50 celecoxib 50 Circulation Heart Failure 50 Ovarian Cancer Screening 50 http:/www.orexigen.com 50 NCCAM 50 pioglitazone hydrochloride 50 www.dnb.com 50 Immune Tolerance Network 50 Psychiatric Services #:#-#,# 50 http:/www.torreypinestherapeutics.com 50 programs visit http:/www.nih.gov 50 N Engl J 50 www.biosantepharma.com 50 Cardiac Allograft Rejection 50 antiplatelet medications 50 www.verispan.com 50 Complications Trial 50 genotypic resistance 50 multicenter randomized placebo controlled 50 tolvaptan 50 Bifantis 50 Cardiol 50 www.adeonapharma.com 50 boosted protease inhibitor 50 recurrent metastatic ovarian cancer 50 Clinical Oncology Annual Meeting 50 Biological Therapy 50 pazopanib 50 Adventrx Pharmaceuticals Inc 50 Nissen meta analysis 50 #:#-# [007] 50 pregabalin Lyrica 50 www.dfwama.com 50 PloS Medicine 50 HOPE TOO 50 visit www.skincancer.org 50 www.tranzyme.com